[Evaluation of chemoantibiotics resistance of gram-negative bacteria isolated from urinary tract infections (author's transl)]. 1981

I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013415 Sulfalene Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria. Sulfamethopyrazine,Sulfamethoxypyrazine,Sulfapyrazinmethoxine,Kelfizine,Longum,Sulfametopyrazine,Sulphalene,Sulphametopyrazine
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1978, Annali Sclavo; rivista di microbiologia e di immunologia,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1988, Mikrobiyoloji bulteni,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1984, Infection and immunity,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 2023, Infectious disorders drug targets,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
July 1986, Mikrobiyoloji bulteni,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1977, Pathologie-biologie,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1991, Mikrobiyoloji bulteni,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
April 1974, La Nouvelle presse medicale,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
September 1980, Quaderni Sclavo di diagnostica clinica e di laboratorio,
I Pasargiklian, and G Nardi, and M L Ribero, and A Pagano
January 1978, Annali Sclavo; rivista di microbiologia e di immunologia,
Copied contents to your clipboard!